What it means
Senescence is a permanent halt to cell division, triggered by DNA damage, short telomeres, oncogene activation or stress. It evolved as a cancer brake: a damaged cell that cannot divide cannot become a tumour. The problem is that senescent cells do not die; they persist and secrete a cocktail of inflammatory cytokines, proteases and growth factors called the senescence-associated secretory phenotype, or SASP.
A small number of senescent cells can degrade the function of the tissue around them — which is why they are called "zombie cells" in the popular press — and their numbers rise with age in nearly every organ.
Why it matters for longevity
The SASP is a major source of inflammaging, the low-grade chronic inflammation that tracks with frailty, cardiovascular disease and loss of muscle. In mice, clearing senescent cells extends healthy lifespan and reverses several age-related deficits, which is why senolytics — drugs that kill senescent cells selectively — are one of the most active areas of longevity research.
What the evidence says
The landmark animal work is Baker et al. 2011 and 2016 (Nature): genetically clearing p16-positive cells in mice delayed tumours, cataracts and muscle loss and extended median lifespan by about 25%. Senolytic drug combinations (dasatinib plus quercetin) reproduced parts of this in older mice.
In humans the evidence is pilot-scale. Justice et al. 2019 gave dasatinib plus quercetin to 14 people with lung fibrosis and reported improved walking distance, no control group. Hickson 2019 showed reduced senescent-cell markers in fat and skin of 9 people with diabetic kidney disease after three days. Larger controlled trials are running; none has reported outcomes.
How to measure or use it
- There is no routine blood test for senescent-cell burden. Research uses tissue biopsies stained for p16 or SA-β-gal, or SASP factor panels.
- The accessible proxy is hs-CRP with IL-6 where available: low chronic inflammation is consistent with low senescent load.
- What lowers senescent burden in humans with evidence: exercise, weight loss and not smoking. Senolytic drugs remain research-only and are not something to self-experiment with.
Related
- Inflammation and immunity — where the SASP fits
- The longevity drugs — senolytics next to the other candidates
- Thymosin alpha-1 — a research peptide studied for immune regulation
Frequently asked questions
Are senescent cells all bad?
No. They stop damaged cells becoming cancer and help wound healing. The problem is accumulation with age, not their existence.
Can I measure my senescent-cell burden?
Not with a standard lab test. hs-CRP and IL-6 are rough proxies; the real measures need tissue.
Does exercise clear senescent cells?
Exercise is associated with lower senescent-cell markers in muscle and fat in several human studies, and is currently the best-evidenced lever.
Want this applied to your own numbers?
Fifteen minutes of intake, your labs, a human-reviewed protocol within about 24 hours, three documents, a free coach call and check-ins through the cycle. €399, follow-up included.
Build my protocol Book a 15-minute call